 |
|
Novel biomarkers for diabetic kidney disease
Chan-Young Jung, Tae-Hyun Yoo
Kidney Res Clin Pract. 2022;41(Suppl 2):S46-S62. Published online 2022 Sep 30 DOI: https://doi.org/10.23876/j.krcp.22.084
|
|
Citations to this article as recorded by
 Genomic insights into renal diseases: advancements and implications
Nicholas Aderinto, Gbolahan Olatunji, Emmanuel Kokori, Ikponmwosa Jude Ogieuhi, Adetola Emmanuel Babalola, Komolafe Babajide Ayodeji, Muhammadul-Awwal Irodatullah Bisola, Ajekiigbe Victor Oluwatomiwa, Ibukunoluwa V. Ishola
The Egyptian Journal of Internal Medicine.2024;[Epub] CrossRef Steps to understanding diabetes kidney disease: a focus on metabolomics
Hyo Jin Kim, Sang Heon Song
The Korean Journal of Internal Medicine.2024; 39(6): 898. CrossRef A New Era in Diabetic Kidney Disease Treatment: The Four Pillars and Strategies to Build Beyond
Sangyub Han, Sejoong Kim
Electrolytes & Blood Pressure.2024; 22(2): 21. CrossRef Pediatric Diabetic Nephropathy: Novel Insights from microRNAs
Francesca Lanzaro, Annalisa Barlabà, Angelica De Nigris, Federica Di Domenico, Valentina Verde, Emanuele Miraglia del Giudice, Anna Di Sessa
Journal of Clinical Medicine.2023; 12(4): 1447. CrossRef Virtual diagnosis of diabetic nephropathy using metabolomics in place of kidney biopsy: The DIAMOND study
Da Woon Kim, Hyo Jin Kim, Eun Young Seong, Sang Soo Kim, Sujin Lee, Suhkmann Kim, Chae Hwa Kwon, Sang Heon Song
Diabetes Research and Clinical Practice.2023; 205: 110986. CrossRef
|